Ramipril Dosing Recommendations
For adults with hypertension, start ramipril at 2.5 mg once daily and titrate to a usual maintenance range of 2.5-20 mg daily; for post-MI heart failure, initiate at 2.5 mg twice daily (or 1.25 mg twice daily if hypotensive) and titrate toward 5 mg twice daily. 1
Standard Adult Dosing
Hypertension
- Starting dose: 2.5 mg once daily in patients not receiving diuretics 1
- Maintenance range: 2.5-20 mg daily, administered as a single dose or divided into two equal doses 1
- Titration: Adjust according to blood pressure response 1
- If antihypertensive effect diminishes toward the end of the dosing interval with once-daily administration, consider increasing the dose or switching to twice-daily dosing 1
- A diuretic may be added if blood pressure is not adequately controlled with ramipril alone 1
Post-Myocardial Infarction Heart Failure
- Starting dose: 2.5 mg twice daily (5 mg total daily) 2, 1
- For hypotensive patients, reduce to 1.25 mg twice daily 1
- Target dose: 5 mg twice daily 2, 1
- Titrate upward (if tolerated) after one week at the starting dose, with dosage increases approximately 3 weeks apart 1
- After the initial dose, observe the patient under medical supervision for at least 2 hours and until blood pressure stabilizes for an additional hour 1
The ACC/AHA guidelines specifically recommend ramipril starting at 2.5 mg twice daily and titrating to 5 mg twice daily as tolerated for patients with anterior infarction, post-MI left ventricular systolic dysfunction (EF ≤0.40), or heart failure 2
Renal Impairment Adjustments
In patients with creatinine clearance >40 mL/min, use usual dosing regimens; for CrCl ≤40 mL/min, reduce initial doses by 75% as 25% of the usual dose produces full therapeutic ramiprilat levels. 1
Hypertension with Renal Impairment
- Initial dose: 1.25 mg once daily 2, 1
- Maximum dose: 5 mg total daily 2, 1
- Titrate upward until blood pressure is controlled or maximum dose is reached 1
Heart Failure Post-MI with Renal Impairment
- Initial dose: 1.25 mg once daily 1
- May increase to 1.25 mg twice daily 1
- Maximum dose: 2.5 mg twice daily 1
- Adjust based on clinical response and tolerability 1
Important Monitoring Considerations
- Establish baseline renal function before initiating ramipril 1
- In older adults with diabetes on ACE inhibitors, monitor renal function and serum potassium within 1-2 weeks of initiation, with each dose increase, and at least yearly 2
- Older adults are more susceptible to ACE inhibitor-related reductions in renal function 2
Elderly Patient Considerations
No specific dose reduction is required based on age alone, but elderly patients often have reduced renal function requiring dose adjustment as outlined above. 1
- Ramipril has been well tolerated in elderly patients with mild to moderate hypertension 3
- Starting doses of both 2.5 mg and 5 mg were similarly safe in elderly patients, with no cases of first-dose hypotension reported 3
- Long-term ramipril treatment in elderly hypertensive patients was associated with improvement in some characteristics of intellectual functioning 3
- The drug has a long elimination half-life permitting once-daily administration, which may improve adherence in elderly populations 4, 5
Special Circumstances
Volume Depletion or Renal Artery Stenosis
- If volume depletion (from past or current diuretic use) or renal artery stenosis is suspected, initiate at 1.25 mg once daily 1
- Reduce concomitant diuretic dose if possible to diminish the likelihood of hypotension 1
- The appearance of hypotension after the initial dose does not preclude subsequent careful dose titration 1
Hyperkalemia Risk
- Concomitant administration with potassium supplements, potassium salt substitutes, or potassium-sparing diuretics can lead to increases in serum potassium 1
- One RCT found that moderate-dose ACE inhibitors (including ramipril) are significantly associated with development of hyperkalemia 2
- A low dose of ramipril (1.25 mg once daily) can reduce proteinuria without significantly increasing plasma potassium, which may be advantageous for patients at risk for hyperkalemia 6
Administration Options
- Ramipril capsules should generally be swallowed whole 1
- Alternatively, capsules may be opened and contents sprinkled on approximately 4 oz of applesauce or mixed in 4 oz (120 mL) of water or apple juice 1
- These mixtures can be prepared and stored for up to 24 hours at room temperature or up to 48 hours under refrigeration 1
- Consume the entire mixture to ensure complete dose administration 1
Common Pitfalls to Avoid
- Do not use excessive starting doses in elderly or renally impaired patients, as this increases risk of hypotension and acute kidney injury 1
- Avoid combining with potassium supplements or potassium-sparing diuretics without careful monitoring, as hyperkalemia risk is substantial 2, 1
- Do not assume normal renal function in elderly patients—calculate creatinine clearance before initiating therapy 1
- Monitor closely after initial dosing in post-MI heart failure patients, as hypotension may occur requiring dose adjustment 1